Day: March 28, 2022

CHNC Announces Return of Half a Billion Shares

Written by Customer Service on March 28, 2022. Posted in Public Companies.

HOUSTON, TX, March 28, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – China Infrastructure Construction Corp (OTC: CHNC): CHNC announces that Dante Picazo, its Chief Executive Officer, is surrendering over 500,000,000 shares of the Company’s common stock to the Company. The Company intends to use these shares for potential outstanding board directors that bring to the Company financial and a scientific business acumen, integrity and high ethics; as well as share-based employee benefits under an incentive plan that will permit the issuance of stock options, restricted stock, restricted stock units and other forms of compensation to its partners (employees). This is one of the many benefits that our partners (employees) enjoy and deserve and allows them to empower themselves, since they are the heart that pumps the blood that keeps our...

Alpha Lithium Closes 3,800 Hectare Acquisition in Hombre Muerto, Argentina

Written by Customer Service on March 28, 2022. Posted in Mergers And Acquisitions.

VANCOUVER, British Columbia, March 28, 2022 (GLOBE NEWSWIRE) — Alpha Lithium Corporation (TSX.V: ALLI) (OTC: APHLF) (Germany WKN: A3CUW1) (“Alpha” or the “Company”) is very pleased to announce that it has acquired the right, through its wholly owned Argentine subsidiary, to purchase two mining properties, totaling 3,800 Hectares, situated in the renowned Salar del Hombre Muerto, Argentina. Subsequent to two previous acquisitions in the same salar (see news releases June 15, 2021 and August 24, 2021), Alpha now controls a 100% interest in 5,072 hectares in the Salar del Hombre Muerto and is the second largest landholder (second only to Posco) on the Salta side of the famous salar. All of Alpha’s 5,072 hectares are immediately bordered by Korean giant, Posco, which announced last week that it was investing US$4 billion in Hombre...

Mullen Strengthens Balance Sheet

Written by Customer Service on March 28, 2022. Posted in Earnings Releases And Operating Results.

Company expects to report in excess of $65M in cash and cash equivalents when it files Form 10Q for the second quarter ending March 31Mullen Strengthens Balance Sheet for Upcoming EV Development Programs Mullen Automotive debuted the FIVE EV Crossover on Nov. 17, 2021, at the Los Angeles International Auto Show.BREA, Calif., March 28, 2022 (GLOBE NEWSWIRE) — via InvestorWire — Mullen Automotive, Inc. (NASDAQ: MULN) (“Mullen” or the “Company”), an emerging electric vehicle (“EV”) manufacturer, announces today that it expects to report in excess of $65 million in cash and cash equivalents when it files Form 10Q for the Company’s second quarter ending March 31, 2022. “We’ve made tremendous progress in key areas over the past three months,” said David Michery, CEO and chairman of Mullen Automotive. “With the financing...

Fortress Biotech Reports Record 2021 Financial Results and Recent Corporate Highlights

Written by Customer Service on March 28, 2022. Posted in Earnings Releases And Operating Results.

Record 2021: Net revenue of $68.8 million and proceeds from the successful monetization of our investment in Caelum Biosciences of $56.9 million1 2021 net loss attributable to common stockholders on a GAAP basis was $(64.7) million or $(0.79) per share; 2021 non-GAAP income attributable to common stockholders of $25.5 million or $0.25 per share, as per the non-GAAP tables below Positive top-line results from registration-enabling study of cosibelimab in metastatic cutaneous squamous cell carcinoma announced in January 2022; BLA submission expected in 2022 Cyprium Therapeutics, a Fortress subsidiary, and Sentynl Therapeutics, a wholly owned subsidiary of Zydus Lifesciences Ltd., signed a Development and Asset Purchase Agreement for CUTX-101 for the treatment of Menkes disease Rolling NDA submission for CUTX-101 for the treatment of Menkes...

Rapid7 Report: Vulnerability Intelligence Shows Significant Year-Over-Year Increase in Widely Exploited Security Flaws

Written by Customer Service on March 28, 2022. Posted in Public Companies.

BOSTON, March 28, 2022 (GLOBE NEWSWIRE) — Rapid7, Inc. (NASDAQ: RPD), a leading provider of security analytics and automation, today announced the release of its latest Vulnerability Intelligence Report examining the 50 most notable security vulnerabilities and high-impact cyberattacks in 2021. On any given day, security professionals must prioritize and address viable threats from an overwhelming number of reported vulnerabilities. Rapid7 researchers analyze thousands of vulnerabilities each year to understand root causes, dispel misconceptions, and share information on why certain flaws are more likely to be exploited than others. From this research, the team creates a report of the highest priority CVEs based on their likelihood of widespread exploitation. “We research and publish this report to contextualize the vulnerabilities...

XpresSpa Group Announces the Addition of Five New XpresSpa Locations in Istanbul

Written by Customer Service on March 28, 2022. Posted in Public Companies.

This summer, the company will expand its international presence and offer select travel retail and wellness services at New Istanbul Airport NEW YORK, March 28, 2022 (GLOBE NEWSWIRE) — XpresSpa Group, Inc. (Nasdaq: XPSA), a travel health and wellness company, today announced the start of construction on the first of five new locations slated for New Istanbul Airport (“IST”). The expansion is part of the Company’s go-forward plan to extend its services and products across international lines. Scott Milford, XpresSpa Group CEO, said, “We are excited to be able to further expand our international reach in one of the busiest airports in the world. With the pandemic fundamentally changing the way consumers travel in the world, our newest XpresSpa locations will provide a host of health and wellness services all designed to improve...

Prothena Announces FDA Clearance of IND for PRX012, a Subcutaneous Anti-Amyloid Beta Antibody Under Investigation for the Treatment of Alzheimer’s Disease

Written by Customer Service on March 28, 2022. Posted in Public Companies.

Prothena has initiated Phase 1 SAD study of PRX012, under investigation for the treatment of Alzheimer’s diseaseDUBLIN, Ireland, March 28, 2022 (GLOBE NEWSWIRE) — Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical company with a robust pipeline of novel investigational therapeutics built on protein dysregulation expertise, today announced that the U.S. Food and Drug Administration (FDA) has cleared the investigational new drug (IND) application for PRX012, a potential best-in-class anti-amyloid beta (Aβ) antibody in development for the treatment of Alzheimer’s disease (AD). Prothena has initiated the Phase 1 single ascending dose (SAD) study to investigate the safety, tolerability, immunogenicity and pharmacokinetics of PRX012 in both healthy volunteers and patients with AD. Prothena expects to initiate the Phase...

US Nuclear Launching Fundraising Campaign to Send More DroneRADs to Ukraine

Written by Customer Service on March 28, 2022. Posted in Public Companies.

LOS ANGELES, March 28, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – US Nuclear (OTC-QB: UCLE) is launching a fundraising campaign through Fundly.com in order to send more DroneRAD radiation detection drones to Ukraine. With the conflict raging in Ukraine, there is significant concern over a nuclear disaster, either from use of nuclear weapons or as fallout from explosive damage to the local nuclear power plants or other facilities storing radioactive materials (disposal sites, hospitals, labs). US Nuclear has already announced its first DroneRAD going to Ukraine, but is seeking public help in order to raise funds to send more units. Russian troops first took over Chernobyl nuclear facility, which had its necessary power supply disconnected on March 9 due to continued fighting and damage to the electrical lines. At least 20,000 spent...

BoxScore Brands, Inc. Announces Corporate Update

Written by Customer Service on March 28, 2022. Posted in Public Companies.

LAS VEGAS, March 28, 2022 (GLOBE NEWSWIRE) — BoxScore Brands, Inc (OTC Pink Current: BOXS) (“BoxScore”, the “Company”) a U.S.-based renewable energy company focused on the extraction, refining, manufacturing, and distribution of precious technical minerals, is pleased to announce a corporate update. “On behalf of all of us at BoxScore Brands, I would like to sincerely thank our shareholders for their patience and encouragement over the past several months. We have spent a tremendous amount of time working and relationship building to ensure that our business plan and corporate structure have solid foundations for future growth, and we are very excited about the future of the company,” stated Andrew Boutsikakis, CEO of BoxScore. “As stated in our February 14thnews release, we are deeply focused on the development and advancement...

Isracann Biosciences Signs Definitive Agreement to Acquire Natural Health Medicine Developer

Written by Customer Service on March 28, 2022. Posted in Mergers And Acquisitions.

VANCOUVER, British Columbia, March 28, 2022 (GLOBE NEWSWIRE) — Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company”) is pleased to announce that, further to the Company’s news release dated February 23, 2022, it has entered into a definitive agreement (the “Agreement”) dated March 24, 2022 with Praesidio Health Inc. (“Praesidio”). Pursuant to the Agreement, the Company will acquire all of the issued and outstanding shares in the capital of Praesidio (the “Praesidio Shares”) for aggregate consideration of C$4,000,000 in common shares (the “Consideration Shares”) of the Company (the “Transaction”). Upon closing of the Transaction (“Closing”), Praesidio will operate as a wholly-owned subsidiary of the Company. Praesidio Health (https://www.praesidiohealth.com/) is an industry-leading, Canadian medical research...

Day: March 28, 2022

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals